InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,142.80
(
-0.17%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.47
(
0.34%
)
Bitcoin
60,851.85
(
-1.55%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 60
Posts 11518
Boards Moderated 0
Alias Born 07/16/2006

jbog

Member Level

Re: vidpok45 post# 79417

Wednesday, 12/07/2016 7:51:50 AM

Wednesday, December 07, 2016 7:51:50 AM

Post# of 80490
vidpok,

Ceritinib was approved in 2014 as a 2nd line after Criz just like the Alta trial patients. Brigs results are close to double those of Ceritinib.


Novartis in the 1st line trial went head to head against Chemo which hasn't been sed in years.

Todays standard 1st line tretment is Criz and that's what it should be tested against.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up